270 related articles for article (PubMed ID: 23653837)
21. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
22. Clinical management of abnormal Pap tests: differences between US and Korean guidelines.
Won S; Kim MK; Seong SJ
J Pathol Transl Med; 2020 May; 54(3):213-219. PubMed ID: 32460475
[TBL] [Abstract][Full Text] [Related]
23. Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
Jung S; Lee B; Lee KN; Kim Y; Oh EJ
Arch Pathol Lab Med; 2016 Mar; 140(3):276-80. PubMed ID: 26927723
[TBL] [Abstract][Full Text] [Related]
24. Management of cervical cytologic abnormalities.
Apgar BS; Brotzman G
Am Fam Physician; 2004 Nov; 70(10):1905-16. PubMed ID: 15571057
[TBL] [Abstract][Full Text] [Related]
25. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement.
Kim M; Kong TW; Kim S; Kim SC; Kim YB; Kim JW; Park JY; Suh DH; Shim SH; Lee KH; Lee SJ; Lee JK; Lim MC
J Gynecol Oncol; 2019 Sep; 30(5):e104. PubMed ID: 31328466
[TBL] [Abstract][Full Text] [Related]
26. Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology.
Oh EJ; Jung CK; Kim DH; Kim HK; Kim WS; Jin SY; Yoon HK;
J Pathol Transl Med; 2017 Nov; 51(6):579-587. PubMed ID: 28950443
[TBL] [Abstract][Full Text] [Related]
27. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
28. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
Obstet Gynecol; 2013 Apr; 121(4):829-846. PubMed ID: 23635684
[TBL] [Abstract][Full Text] [Related]
29. Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.
Min CJ; Massad LS; Dick R; Powell MA; Kuroki LM
J Low Genit Tract Dis; 2020 Oct; 24(4):337-342. PubMed ID: 32976292
[TBL] [Abstract][Full Text] [Related]
30. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S1-S27. PubMed ID: 23519301
[TBL] [Abstract][Full Text] [Related]
31. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
33. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
[TBL] [Abstract][Full Text] [Related]
34. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
Khan KA; Smith DA; Thrall MJ
Arch Pathol Lab Med; 2013 Jul; 137(7):936-41. PubMed ID: 22994456
[TBL] [Abstract][Full Text] [Related]
35. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
36. Atypical squamous cells: update on current concepts.
Nayar R; Tabbara SO
Clin Lab Med; 2003 Sep; 23(3):605-32. PubMed ID: 14560531
[TBL] [Abstract][Full Text] [Related]
37. Prospective and retrospective review of gynecologic cytopathology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 2.
Brainard JA; Birdsong GG; Elsheikh TM; Hartley DA; Naik K; Neal MH; Souers RJ; Henry MR
Arch Pathol Lab Med; 2013 Feb; 137(2):175-82. PubMed ID: 23368859
[TBL] [Abstract][Full Text] [Related]
38. Potential hazards of following atypical and low-grade cervical cytology without colposcopy.
Nyirjesy I; Billingsley FS
Prim Care Update Ob Gyns; 1998 Jul; 5(4):162. PubMed ID: 10838302
[TBL] [Abstract][Full Text] [Related]
39. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
[TBL] [Abstract][Full Text] [Related]
40. Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines.
Cho HW; Min KJ; Kwon SH; Kim K; Kim S; Seong SJ; Song YJ; Lee KH; Lee SW; Lee JW; Ju W; Kim YT; Lee JK
J Gynecol Oncol; 2021 Nov; 32(6):e94. PubMed ID: 34708596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
